Target intelligence / Profile preview

Pathogenic microRNA

Molecular classification
Other (non-coding RNA, microRNA family)
01

Overview

Pathogenic microRNA refers to any microRNA molecule, either host-derived or pathogen-derived, whose altered expression or activity contributes to the development or progression of disease. These miRNAs may promote oncogenesis (as oncomiRs), viral replication, immune evasion, or pathological inflammation by post-transcriptionally regulating target genes involved in cell survival, immune response, and signaling pathways. Examples include viral miRNAs (from herpesvirus, cytomegalovirus, etc.) that suppress host immune genes, or dysregulated host miRNAs in cancer and autoimmune disease. Because the term applies to a functional group rather than a discrete entity, therapeutic targeting is done at the level of specific miRNAs, employing antisense oligonucleotides, miRNA mimics, and other molecular inhibitors.

Other names
Pathogenic miRNAdisease-associated miRNAviral miRNAoncomiRpathogenic non-coding RNA
02

Mechanism of action

Drugs that modulate pathogenic miRNA typically act by: Antagonizing (blocking) disease-associated miRNAs (antagomirs); Restoring or mimicking tumor suppressor miRNAs; Modulating miRNA maturation or stability

03

Biological functions

Post-transcriptional gene regulationImmune response modulationCell proliferationCell deathSignal transductionApoptosisInflammationOther (latency maintenance, viral replication, cytokine signaling inhibition)
04

Disease associations

Cancer (oncogenic miRNAs/oncomiRs and tumor suppressor miRNAs)Infection (viral and bacterial miRNAs modulate host defense and promote survival of pathogens)InflammationRheumatoid arthritis and other autoimmune/inflammatory diseasesNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Off-target effects and toxicity due to miRNA pleiotropy (one miRNA regulates many genes)Difficulties in delivery and stability for RNA-based therapeuticsRisk of unintended immune activation or suppression
06

Biomarkers

Diagnosis (e.g., expression pattern in blood/exosomes for cancer, autoimmune disease)Prognosis (miRNA profiles in patient tissues or fluids)Treatment response (miRNA changes in response to therapy)

Beyond the preview

Go deeper on Pathogenic microRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic microRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call